Inovio Pharmaceuticals, Inc.
NASDAQ:INOBiotechnology
Healthcare
$1.71 -0.90%
-$0.01 today
- Market cap
- $118.15M
- Beta
- 1.49
- P/E (TTM)
- -8.9
- EPS (TTM)
- -$0.12
52W Low $1.03High $2.98
Volume 9.92M
Average 2.73M
Price history
Inovio Pharmaceuticals, Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-1.16%
Period high
$2.60
Period low
$0.74
Latest
$1.71
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 424B5 | Nov 6, 2026 | Nov 6, 2026 | |
| FWP | Nov 6, 2026 | Nov 5, 2026 | |
| 424B5 | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G/A | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 2, 2026 | Nov 2, 2026 | |
| 8-K | Oct 6, 2026 | Oct 6, 2026 | |
| SC 13G/A | Aug 12, 2026 | Aug 12, 2026 | |
| 10-Q | Aug 12, 2026 | Aug 12, 2026 | |
| 8-K | Aug 12, 2026 | Aug 12, 2026 | |
| SC 13G | Aug 7, 2026 | Aug 7, 2026 | |
| SC 13G/A | Aug 6, 2026 | Aug 6, 2026 | |
| 8-K | Jul 31, 2026 | Jul 31, 2026 | |
| SC 13G | Jul 31, 2026 | Jul 31, 2026 | |
| 424B5 | Jul 30, 2026 | Jul 30, 2026 |
Competitors
Who does Inovio Pharmaceuticals, Inc. compete with?
Open similar companies to compare their filings and price history.
Questions
Filing questions
Common questions about INO's filings, answered from its disclosures.
What is the latest INO filing?
The latest filing shown is 424B5 dated Nov 6, 2026.
How many recent filings does INO have?
Intrinsic Alpha currently shows 20 recent filings for INO.
Continue the stock analysis
Jump to another research area for this company.